Drug Profile
Transforming growth factor-beta antibody - Eli Lilly and Company
Alternative Names: TGF-beta antibody - Eli Lilly and CompanyLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Eli Lilly and Company
- Class Antibodies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Kidney disorders; Solid tumours
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Kidney-disorders in USA (Parenteral)
- 16 Jul 2016 No recent reports of development identified for phase-I development in Solid-tumours in USA (Parenteral)
- 11 Dec 2008 Phase-I clinical trials in Kidney disorders in USA (Parenteral)